Immunotherapy with T‐cell‐reactive peptides derived from allergens

Allergy

Volumn 49, Issue 5, 1994, Pages 302-308

  Gefter, M L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; LYMPHOKINE; SYNTHETIC PEPTIDE;

ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ALLERGENS; AMINO ACID SEQUENCE; ANIMAL; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CATS; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; EPITOPES; GLYCOPROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMAN; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR SEQUENCE DATA; PEPTIDES; T-LYMPHOCYTES;

EID: 0028287894     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1994.tb02272.x     Document Type: Review

References (71)

1. In vivo competition between self peptides and foreign antigens in T cell activation
2. T lymphocyte activation: a biological model of signal transduction
3. Reversal of in vitro T cell clonal anergy by IL‐2 stimulation
4. Antigen presentation pathways to class I and class II MHC restricted T lymphocytes
5. Peripheral T cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen, Fel d I
6. Three‐dimensional structure of the human class II histocompatibility antigen HLA‐DR1
7. T cell epitopes of the major fraction of ryegrass Loliuni perenne (Lol p I) defined using overlapping peptides in vitro and in vivo. I. Isoallergen clone 1A
8. Aqueous antigens induce in vivo tolerance selectively in IL‐2 and IFN‐γ producing (Thl) cells
9. Degenerate binding of immunogenic peptides to HLA‐DR proteins on B cell surfaces
10. Antigen‐related T‐cell receptor diversity and self‐nonself homology
11. Immunologic changes associated with immunotherapy
12. Dose response of IgE and IgG antibodies during ragweed immunotherapy
13. The presumptive CDR3 regions of both T cell receptor y. and P chains determine T cell specificity for myoglobin peptides
14. Small B cells as antigen‐presenting cells in the induction of tolerance to soluble protein antigens
15. IL‐10 acts on the antigen presenting cell to inhibit cytokine production by TH, cells
16. The induction of peripheral T cell unresponsiveness in adult mice by monomeric human γ‐globulin
17. The dominant self and the cryptic self; shaping the autoreactive T‐cell repertoire
18. The choice of T cell epitopes utilized on a protein antigen depends on multiple factors distant from as well as at the determinant site
19. Anti‐CD40 monoclonal antibodies or CD4 + T cell clones and IL‐4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways
20. Induction of human IgE synthesis in B cells by mast cells and basophils
21. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide‐induced anergy
22. Ragweed immunotherapy decreases T cell reactivity to recombinant Ambal. I. [Abstract]
23. Immunological self, nonself discrimination
24. Interaction of peptide antigens and class II major histocompatibility complex antigens
25. Promiscuous and allele‐specific anchors in HLA‐DR‐binding peptides
26. T cell determinants in the group II allergen of D. pteronvssinus
27. Lymphocyte responsiveness to Dermatophagoides farinae extract in mite‐sensitive patients: effect of immunotherapy on cellular proliferative response and specific immunoglobulin E antibody (Rast score)
28. The role of cell division in the induction of clonal anergy
29. Antigen presentation by chemically modified splenocytes induces antigen‐specific T cell unresponsiveness in vitro and in vivo
30. T cell tolerance by clonal elimination in the thymus
31. Prevention of experimental autoimmune arthritis with a peptide fragment of type II collagen
32. Monocyte chemotactic and activating factor is a potent histamine‐releasing factor for human basophils
33. Epitope mapping of T cell recognition of phospholipase A2 [Abstract]
34. Induction of tolerance in influenza virus‐immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin
35. IgE‐dependent histamine‐releasing factor: a unique cytokine
36. Antigen‐specific interaction between T and B cells
37. Mediation of local homeostasis and inflammation by leukotrienes and other mast cell dependent compounds
38. IgE antibody measurements in ragweed hay fever: relationship to clinical severity and the results of immunotherapy
39. 2
40. IL‐10, a novel growth cofactor for mature and immature T cells
41. Reciprocal regulatory effects of IFN‐γ and IL‐4 on the in vitro development of human Th1 and Th2 clones
42. Do B cells drive the diversification of immune responses
43. Interleukin‐8 and Mcaf: novel inflammatory cytokines inducible by IL‐1 and TNF
44. Antigen‐driven bystander suppression after oral administration of antigen
45. Determination of the amino acid sequence of Fel d I, the major allergen of the domestic cat: protein sequence analysis and cDNA cloning
46. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties
47. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
48. T cell mediated immunosuppression
49. Inflammatory mediators in late antigen‐induced rhinitis
50. The clinical significance of IgE
51. Clonal anergy: persistence in tolerant mice of antigen‐binding B lymphocytes incapable of responding to antigen or mitogen
52. The biologic activity of mast cell granules for causing late phase reactions
53. Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy
54. Allergens of mammalian origin. III. Properties of a major feline allergen
55. On the interaction of promiscuous antigenic peptides with different DR alleles
56. Cytokine regulation of T cell function: potential for therapeutic intervention
57. Induction of classical transplantation tolerance in the adult
58. Immunological activity of covalently linked T cell epitopes
59. Human TH1 and TH2 subsets
60. Interactions between immunogenic peptides and MHC proteins
61. Murine MHC polymorphism and T cell specificities
62. Control of cellular and humoral immune responses by peptides containing T‐cell epitopes
63. Acquisition of immunologic self‐tolerance
64. A cell culture model for T lymphocyte clonal anergy
65. The dendritic cell system and its role in immunogenicity
66. Systemic reactions from allergen immunotherapy
67. Murine MHC polymorphism and T cell specificities
68. Antigen processing and presentation at a molecular level
69. Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens
70. The costimulatory function of antigen ‐presenting cells
71. The T lymphocyte in experimental allergic encephalomyelitis